Prelude Therapeutics
PRLD
$3.93
Share price
0.77%
Change (1 day)
-29.32%
Change (1 year)
Categories
Prelude Therapeutics (PRLD) - P/B ratio
P/B ratio as of June 2024 : 1.02
According to Prelude Therapeutics's latest financial reports the company has a price-to-book ratio of 1.02.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Prelude Therapeutics - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 0.9875 | -33.22% |
| 2022-12-31 | 1.48 | -28.67% |
| 2021-12-31 | 2.07 | -85.93% |
| 2020-12-31 | 14.7 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.53 | 49.00% | 🇺🇸 USA |